Approval · Notice of Compliance 18114 · 2016
LUTREPULSE: Notice of Compliance 18114
Issued May 20, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18114
- Date
- May 20, 2016
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the dosage and administration section of the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUTREPULSE | Not yet assigned | — |
Medicinal ingredients
- GONADORELIN ACETATE 3.2 MG per VIAL